18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2 other identifiers
interventional
1,306
2 countries
121
Brief Summary
The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patients participating in this study will take orally once daily xaliproden or placebo (inactive substance pill).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 alzheimer-disease
Started Nov 2003
Typical duration for phase_3 alzheimer-disease
121 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedFirst Submitted
Initial submission to the registry
February 11, 2005
CompletedFirst Posted
Study publicly available on registry
February 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedAugust 21, 2008
August 1, 2008
3.9 years
February 11, 2005
August 20, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Alzheimer's Disease assessment scale-cognitive, clinical dementia rating sum of boxes.
Secondary Outcomes (1)
Mini-Mental State Examination, Alzheimer's Disease assessment scale-activities of daily life.
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of probable Alzheimer's disease using NINCDS-ADRDA criteria
- Mild to moderate degree of severity of dementia as assessed by the Mini-Mental State Examination score of 16 to 26 (inclusive)
- Potential participant may be treated with conventional Alzheimer's disease therapy and must be on stable dose for at least 6 months prior to the randomization and during the entire study period
- Potential participant must have a reliable caregiver and must be living in a community or in an assisted living facility
- Mother tongue is English, Spanish or French (oral and written fluency)
- Signed informed consent from potential participant or legal representative and identified caregiver
You may not qualify if:
- Potential participant with any other cause of dementia.
- Potential participant with serious health problems other than Alzheimer's disease
- Use of an investigational drug within two months prior to randomization or during this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sanofilead
Study Sites (121)
UAB Memory Disorders Clinic
Birmingham, Alabama, 35294-0017, United States
Barrow Neurology Clinics
Phoenix, Arizona, 85013, United States
PsyPharma Clinical Research, Inc.
Phoenix, Arizona, 85050, United States
Radiant Research
Scottsdale, Arizona, 85251, United States
Anaheim Research Center
Anaheim, California, 92801, United States
Margolin Brain Institute
Fresno, California, 93720, United States
Coordinated Clinical Research
La Jolla, California, 92037, United States
Senior Clinical Trials, Inc.
Laguna Hills, California, 92653, United States
Pharmacology Research Institute
Newport Beach, California, 92660, United States
Pharmacology Research Institute
Northridge, California, 91324, United States
Pharmacology Research Institute
Riverside, California, 92506, United States
Pacific Research Network
San Diego, California, 92103, United States
California Neuroscience Research Medical Group
Sherman Oaks, California, 91403, United States
Pacific Research Network
Vista, California, 92083, United States
Radiant Research
Denver, Colorado, 80212, United States
Associated Neurologist
Danbury, Connecticut, 06810, United States
Geriatric and Adult Psychiatry, LLC
Hamden, Connecticut, 06518, United States
Yale University School of Medicine AD Research Unit
New Haven, Connecticut, 06510, United States
Healthcore
Newark, Delaware, 19713-2094, United States
Neurology Associates, PA
Wilmington, Delaware, 19806, United States
Atlantic Institute of Clinical Research
Daytona Beach, Florida, 32114, United States
Berma Research Group
Hialeah, Florida, 33016, United States
Miami Research Associates
Miami, Florida, 33173, United States
Baumel-Eisner Neuromedical Institute in Miami Beach
Miami, Florida, United States
Baumel-Eisner Neuromedical Institute
Miami, Florida, United States
Anchor Research Center
Naples, Florida, 34102, United States
Segal Institute for Clinical Research
North Miami, Florida, 33161, United States
Clinical Neuroscience Solutions
Orlando, Florida, 32806, United States
Palm Beach Neurological Center
Palm Beach Gardens, Florida, 33410, United States
Neurology Clinical Research, Inc.
Plantation, Florida, 33324, United States
CNS Clinical Trials
St. Petersburg, Florida, 33702, United States
Baumel-Eisner Neuromedical Institute in Miami Beach
Tamarac, Florida, United States
Meridien Research
Tampa, Florida, 33609, United States
Suncoast Gerontology Center USF
Tampa, Florida, 33617, United States
Radiant Research
Marietta, Georgia, 30060, United States
Southeastern Geriatric Healthcare
Snellville, Georgia, 30078, United States
Chicago Center for Clinical Research
Chicago, Illinois, 60610, United States
Radiant Research Center
Hoffman Estates, Illinois, 60194, United States
Elkhart Clinic, LLC
Elkhart, Indiana, 46514, United States
Ruan Neurology
Des Moines, Iowa, 50314, United States
Four Rivers Clinical Research
Paducah, Kentucky, 42003, United States
Louisiana Research Associates
New Orleans, Louisiana, 70114, United States
J. Gary Booker MD
Shreveport, Louisiana, 71101, United States
Clinical Insights
Glen Burnie, Maryland, 21061, United States
Summit Research Network Michigan, Inc.
Okemos, Michigan, 48864, United States
Pivotal Research Centers, Detroit Office
Royal Oak, Michigan, 48073, United States
Minneapolis VA Medical Center
Minneapolis, Minnesota, 55417, United States
Radiant Research
Las Vegas, Nevada, 89146, United States
ClinSearch, Inc.
Kenilworth, New Jersey, 07033, United States
The Neuroscience Center of Northern New Jersey
Morristown, New Jersey, 07960, United States
Princeton Medical Institute
Princeton, New Jersey, 08540, United States
Neurology Group of Bergen County
Ridgewood, New Jersey, 07450, United States
Lovelace Scientific Resources
Albuquerque, New Mexico, 87108, United States
Neurological Association of Albany P.C.
Albany, New York, 12208, United States
Social Psychiatry Research Institute
Brooklyn, New York, 11235, United States
Parker Jewish Institute for Healthcare and Rehabilitation
Hyde Park, New York, 11021, United States
Neurobehavioral Research, Inc.
Lawrence, New York, 11559, United States
Eastside Comprehensive Medical Center
New York, New York, 10021, United States
Behavioral Medical Research of Staten Island
New York, New York, 10305, United States
Global Research and Consulting
Olean, New York, 14760, United States
Duke University Medical Center (DUMC) - Dept. of Psychiatry
Durham, North Carolina, 27710, United States
MedARK Clinical Research
Morganton, North Carolina, 28655, United States
Piedmont Medical Research Assoc, Inc.
Winston-Salem, North Carolina, 27103, United States
DayStar Clinical Research, Inc.
Akron, Ohio, 44313, United States
North East Ohio Health Services
Beachwood, Ohio, 44122, United States
Valley Medical Primary Care
Centerville, Ohio, 45459, United States
Remington-Davis Clinical Research
Columbus, Ohio, 43215, United States
Triphase Research, Ltd.
Franklin, Ohio, 45005, United States
TriPhase Research
Franklin, Ohio, 45005, United States
Neurology and Neuroscience Center of Ohio
Toledo, Ohio, 43623, United States
Radiant Research Eugene
Eugene, Oregon, 97455, United States
Clinical Research Institute of Southern Oregon
Medford, Oregon, 97504, United States
Summit Research Network Inc
Portland, Oregon, 97210, United States
Coatesville VA Medical Center
Coatesville, Pennsylvania, 19320, United States
Pearl Clinical Research
Norristown, Pennsylvania, 19401, United States
Memory Disorders Clinic
Philadelphia, Pennsylvania, 19104, United States
Radiant Research
Philadelphia, Pennsylvania, 19115, United States
Clinical Trials Research Services
Pittsburgh, Pennsylvania, 15206, United States
JRMC Clinical Trials Center
Pittsburgh, Pennsylvania, 15236, United States
RI Mood and Memory
East Providence, Rhode Island, 02914, United States
Memorial Hospital of Rhode Island
Pawtucket, Rhode Island, 02860, United States
Avera Research Institute
Sioux Falls, South Dakota, 57105, United States
CNS Healthcare
Memphis, Tennessee, 38119, United States
Vanderbilt University Medical Center - Geriatric Psychiatry
Nashville, Tennessee, 37212, United States
University of Texas - Southwestern Medical Center at Dallas
Dallas, Texas, 75390-9129, United States
Houston Sleep Center
Houston, Texas, 77024, United States
AD Research Center
Houston, Texas, 77030, United States
Innovative Clinical Trials
San Antonio, Texas, 78229, United States
North Texas Neurology Research
Wichita Falls, Texas, 76301, United States
Radiant Research SLC
Salt Lake City, Utah, 84107, United States
The Memory Clinic
Bennington, Vermont, 05201, United States
Charlottesville Medical Research
Charlottesville, Virginia, 22911, United States
Internal Medicine Northwest
Tacoma, Washington, 98405, United States
Wenatchee Valley Medical Center
Wenatchee, Washington, 98801, United States
Dean Foundation
Middleton, Wisconsin, 53562, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
IPC Research
Waukesha, Wisconsin, 53188, United States
Glenrose Rehabilitation Hospital
Edmonton, Alberta, T5G 0B7, Canada
Unknown Facility
Kelowna, British Columbia, V1Y 3G8, Canada
Medical Arts Health Research Group
Penticton, British Columbia, V2A 5C8, Canada
Can-Med Clinical Research Inc.
Victoria, British Columbia, V8T 5G1, Canada
Winnipeg Clinic
Winnipeg, Manitoba, H1T 2H4, Canada
Winnipeg Clinic
Winnipeg, Manitoba, R3C 0N2, Canada
Davidson Memory Clinic
Moncton, New Brunswick, E1C 4B7, Canada
St. Joseph's Hospital
Saint John, New Brunswick, E2L 3L6, Canada
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8G 5E4, Canada
Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
St. Joseph's Health Care
London, Ontario, N6A 4V2, Canada
Parkwood Hospital - Geriatric Medicine
London, Ontario, N6C 5J1, Canada
Parkinson's & Neurodegenerative Disorders
Ottawa, Ontario, K1G 4G3, Canada
S.C.O. Health Centre
Ottawa, Ontario, K1N 5C8, Canada
Toronto Memory Program
Toronto, Ontario, M3B 2W7, Canada
University Health Network - The Toronto
Toronto, Ontario, M5T 2S8, Canada
NeuroSearch Developments Inc
Greenfield Park, Quebec, J4V 2J2, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2H4, Canada
Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Centre de Hospitalier Affilie
Québec, Quebec, G1J 1Z4, Canada
Quebec Memory & Motor Skills Disorders
Québec, Quebec, G1R 3X5, Canada
Institut Universitaire de Geriatrie de Sherbrooke
Sherbrooke, Quebec, J1J 3H5, Canada
Douglas Hospital Research Centre
Verdun, Quebec, H4H 1R3, Canada
Pasqua Hospital
Regina, Saskatchewan, S4T 1A5, Canada
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ICD CSD
Sanofi
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 11, 2005
First Posted
February 14, 2005
Study Start
November 1, 2003
Primary Completion
October 1, 2007
Study Completion
October 1, 2007
Last Updated
August 21, 2008
Record last verified: 2008-08